Ole Jannik Bjerrum

Ole Jannik Bjerrum

Medicine

1979 …2019

Research activity per year

Network

Laila Eljaja

  • Institut for Farmakologi og Farmakoterapi

External person

Merete Schmiegelow

  • NovoNordisk A/S

External person

Malcolm Rowland

  • University of Manchester

External person

Mikael Thomsen

  • Conrig Pharma A/S

External person

Yvonne Gautam

  • NovoNordisk A/S

External person

Pernille Kristensen

  • Institut for Farmakologi og Farmakoterapi

External person

Gordon Munro

  • NeuroSearch
  • H. Lundbeck A/S

External person

Mette Richner

  • Aarhus University

External person

Pia Møllgaard

  • Institut for Farmakologi og Farmakoterapi

External person

Richard John Weaver

  • Servier Group,

External person

Lene Munkholm Andersen

  • Institut for Farmakologi og Farmakoterapi

External person

Ming Ding

  • University of Southern Denmark

External person

J. Brian Houston

  • Centre for Applied Pharmacokinetic Research, School of Pharmacy and Pharmaceutical Sciences, University of Manchester

External person

Roeline Jochemsen

  • Servier Group

External person

Christian B. Vaegter

  • Aarhus University

External person

Peter Thygesen

  • Novo Nordisk A/S (Biz)

External person

Stephen Butler

  • Pain clinic, Department of anesthesiology and intensive care, University of Uppsala, Sweden

External person

Jørgen Dirac

  • NovoNordisk A/S

External person

Hans J. Bjerrum

  • Psychiatry Practice

External person

Erik Dupontd

  • Aarhus University

External person

Berend Oosterhuis

  • PRA International BV, P.O. Box 200, 9470 AE Zuidlaren, The Netherlands

External person

Yoko Shishikura

  • Xceleron Ltd.

External person

Athanasia Boulakou

  • Department of Drug Design and Pharmacology

External person

Anders Nykjær

  • Aarhus University

External person

Richard John Weaver

  • Servier Research Institute

External person

Majbritt Larsen

  • Institut for Lægemiddeldesign og Farmakologi

External person

Lene Munkholm Neustrup

  • Institut for Farmakologi og Farmakoterapi

External person

Jan Wiese

  • Martin Luther University Halle-Wittenberg

External person

Frederik Rode

  • Det Farmaceutiske Fakultet, Københavns Universitet

External person

Frank Larsen

  • H. Lundbeck A/S

External person

Kim K Kristensen

  • NovoNordisk A/S, Copenhagen

External person

Signe Neustrup

  • Institut for Farmakologi og Farmakoterapi

External person

Vasiliki Vana

  • Systenmsd pharmacology, Dept drug design and pharmacology, Univ Copenhagen

External person

Niels H. H. Heegaard

  • Statens Serum Institut

External person

Yvonne Gautam

  • Department of Drug Design and Pharmacology

External person

Niels HH Heegaard

  • Statens Serum Institut

External person

Troels Staehelin Jensen

  • Aarhus University

External person

Marc Jochimsen

  • Universität Konstanz

External person

Berend Oosterhuis

  • PRA International BV

External person

Brian Houston

  • University of Manchester

External person

Rajesh Krishna

  • Merck Research Laboratories

External person

Daan J.A. Crommelin

  • Top Institute Pharma

External person

Ann Merry

  • University of Copenhagen

External person

Heidi Foth

  • Martin Luther University Halle-Wittenberg

External person

Graham Lappin

  • Xceleron Ltd.

External person

Colin Garner

  • Xceleron Ltd.

External person

Hans H. Linden

  • European Federation for Pharmaceutical Sciences

External person

Anna Basnet

  • Department of Drug Design and Pharmacology

External person

Gordon Blackburn-Munro

  • Neurosearch A/S, Ballerup

External person

Troels S. Jensen

  • Aarhus University Hospital /Aarhus Universitetshospital

External person

Margareta Butler

  • Pain clinic, Department of anesthesiology and intensive care, University of Uppsala, Sweden

External person

Anette T. Møller

  • Aarhus University Hospital /Aarhus Universitetshospital

External person

Kim Kristensen

  • Novo Nordisk A/S (Biz)

External person

Louise S. Dalbøge

  • Institut for Lægemiddeldesign og Farmakoloig
  • Novo Nordisk A/S

External person

Lisbeth Birk Møller

  • Institut for Natur, Systemer og Modeller

External person

Tine Broløs

  • Det Farmaceutiske Fakultet, Københavns Universitet

External person

Mads Thomsen

  • Det Farmaceutiske Fakultet, Københavns Universitet

External person

Yvonne Gautam

  • Systems pharmacology, Dept Drug design and pharmacology, University of Copenhagen

External person

Pernille Kristensen

  • University of Copenhagen

External person

Merete Schmiegelow

  • Novo Nordisk A/S (Biz)

External person

Vasiliki Vana

  • University of Copenhagen

External person

Vibe Hellmund

  • Aarhus University

External person

Jane Alder

  • University of Manchester

External person

Yoko Shishikura

  • Xceleron Ltd.

External person

Steen H Ingwersen

  • Novo Nordisk A/S (Biz)

External person

Grzegorz Grynkiewicz

  • Pharmaceutical Research Instiut

External person

Sanja Dragovic

  • Vrije Universiteit Amsterdam

External person

Anette Torvin Møller

  • Aarhus University

External person

Torsten E Gordh

  • Pain clinic, Department of anesthesiology and intensive care, University of Uppsala, Sweden

External person

Sidsel Salling Thorborg

  • University of Copenhagen

External person

Charlotte Gesson

  • Servier Research Institute

External person

K. Kristensen

  • Novo Nordisk A/S (Biz)

External person

Lisbeth Birk Møller

  • University of Copenhagen

External person

Graham Lappin

  • Xceleron Ltd.

External person

Hans Guenter Schaefer

  • Boehringer-Ingelheim Pharma GmbH & Co. KG

External person

Chris Vos

  • Vrije Universiteit Amsterdam

External person

Lisbeth B. Møller

  • Copenhagen University Hospital

External person

Roeline Jochemsen

  • Servier Research Institute

External person

Charlotte Gesson

  • Servier Group

External person

Erik Dupont

  • Aarhus University Hospital /Aarhus Universitetshospital

External person